USFDA gives exception to Glenmark Pharma to supply pneumonia drug from Baddi facility

In a regulatory filing, Glenmark said, "...due to medical necessity and potential drug shortage expectations, the USFDA has provided an exception, which enables the Company to supply Atovaquone Oral Suspension USP 750mg/5ml to the US market".
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news